| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Heart and Circulatory Physiology, Vol 269, Issue 6 2017-H2021, Copyright © 1995 by American Physiological Society
ARTICLES |
S. Verma, S. Bhanot and J. H. McNeill
Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
Evidence suggests that hyperinsulinemia may be causally related to the development of high blood pressure (BP) in fructose-hypertensive (FH) rats. Because plasma insulin has been shown to modulate endothelin (ET) release in vivo, we hypothesized that hyperinsulinemia may provide a continual stimulus for ET release, which could increase BP by altering plasma or blood vessel ET levels. To test this hypothesis, we studied the effect of chronic ET-receptor blockade (by using bosentan, a noncompetitive ET antagonist) on plasma insulin levels, plasma ET levels, blood vessel ET content, and BP in FH rats. Chronic oral bosentan treatment (100 mg.kg-1.day-1) was initiated in 6-wk-old Sprague-Dawley rats. One week after bosentan treatment was started, rats were fed either normal rat chow or a fructose-enriched diet. Plasma insulin, plasma glucose, and systolic BP were measured weekly. At termination (in 15-wk-old rats), plasma ET levels and total mesenteric ET content were determined. Bosentan treatment caused a sustained decrease in BP in the FH rats (treated 130 +/- 4 vs. untreated 149 +/- 2 mmHg, P < 0.001) but had no effect in the normotensive control group. FH rats had a higher total mesenteric ET content compared with the control group (21.5 +/- 3.2 vs. 14.1 +/- 2.1 fmol, P < 0.05). Bosentan treatment did not alter total mesenteric ET content (treated 18.8 +/- 5 fmol, P > 0.05 vs. untreated) nor did it affect plasma insulin or ET levels in any group. These data suggest that ET may be involved in the development of high BP in FH rats. Whether ET represents an intermediate, linking hyperinsulinemia to hypertension in rats, or is an independent hypertensinogenic mechanism remains to be determined.
This article has been cited by other articles:
|
|
 |
|
  C.-C. Juan, Y.-W. Shen, Y. Chien, Y.-J. Lin, S.-F. Chang, and L.-T. Ho Insulin infusion induces endothelin-1-dependent hypertension in rats Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E948 - E954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Galipeau, S. Verma, and J. H. McNeill Female rats are protected against fructose-induced changes in metabolism and blood pressure Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2478 - H2484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Galipeau, L. Yao, and J. H. McNeill Relationship among hyperinsulinemia, insulin resistance, and hypertension is dependent on sex Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H562 - H567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Galipeau, E. Arikawa, I. Sekirov, and J. H. McNeill Chronic Thromboxane Synthase Inhibition Prevents Fructose-Induced Hypertension Hypertension, October 1, 2001; 38(4): 872 - 876. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. V. G. Katakam, J. S. Pollock, D. M. Pollock, M. R. Ujhelyi, and A. W. Miller Enhanced endothelin-1 response and receptor expression in small mesenteric arteries of insulin-resistant rats Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H522 - H527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Verma, L. Yao, D. J. Stewart, A. S. Dumont, T. J. Anderson, and J. H. McNeill Endothelin Antagonism Uncovers Insulin-Mediated Vasorelaxation In Vitro and In Vivo Hypertension, February 1, 2001; 37(2): 328 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Brands, A. E. Hailman, and S. M. Fitzgerald Long-Term Glucose Infusion Increases Arterial Pressure in Dogs With Cyclooxygenase-2 Inhibition Hypertension, February 1, 2001; 37(2): 733 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Reinhart, L. C. Preusser, T. J. Opgenorth, C. D. Wegner, and B. F. Cox Endothelin and ETA receptors in long-term arterial pressure homeostasis in conscious nonhuman primates Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2000; 279(5): R1701 - R1706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Claxton, M. W. Brands, S. M. Fitzgerald, and J. A. Cameron Inhibition of Nitric Oxide Synthesis Potentiates Hypertension During Chronic Glucose Infusion in Rats Hypertension, January 1, 2000; 35(1): 451 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Nava, V. Guarner, R. Posadas, I. Perez, and G. Banos Insulin-induced endothelin release and vasoreactivity in hypertriglyceridemic and hypertensive rats Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H399 - H404. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Brands, D. L. Harrison, H. L. Keen, A. Gardner, E. W. Shek, and J. E. Hall Insulin-Induced Hypertension in Rats Depends on an Intact Renin-Angiotensin System Hypertension, April 1, 1997; 29(4): 1014 - 1019. [Abstract] [Full Text]
|
|
|
|
|
|
J. R. Sowers Insulin and Insulin-Like Growth Factor in Normal and Pathological Cardiovascular Physiology Hypertension, March 1, 1997; 29(3): 691 - 699. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
